Search research articles

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sustained disease remission after a limited duration of bispecific antibody therapy in patients with multiple myeloma.

HemaSphere·2026

Same author

Does ciltacabtagene autoleucel have a future in multiple myeloma?

Nature reviews. Clinical oncology·2026

Same author

Six Years Since Selinexor Approval for Relapsed Multiple Myeloma: What Have We Learned?

Cancer investigation·2026

Same author

Reporting of primary endpoint and associated spin in randomized myeloma trials.

The oncologist·2026

Same author

The Association of Age and Frailty With Adverse Events for Bortezomib and Carfilzomib: A Population-Based Analysis.

American journal of hematology·2026

Same author

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy.

Blood cancer journal·2026

Same journal

Knowledge, Perceptions, and Utilization of the Casablanca Cancer Registry among Health Stakeholders in Morocco: An Online Survey.

Journal of cancer policy·2026

Same journal

Science or spin? A descriptive analysis of how oncology trials are presented in three short form digital media outlets.

Journal of cancer policy·2026

Same journal

Determinants of performing breast self-examination in Omani women using health belief model: Confirmatory factor analysis with hierarchical logistic regression.

Journal of cancer policy·2026

Same journal

Integrating early cancer care into one pathway: Comparison across Denmark, the Netherlands and Italy.

Journal of cancer policy·2026

Same journal

Mapping breast cancer care patterns in FARO member countries: A survey.

Journal of cancer policy·2026

Same journal

Coastal cancer care: A blueprint to address the unmet needs through place-based research and policy approaches.

Journal of cancer policy·2026

See all related articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Aug 12, 2025

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

Subgroups and precision in myeloma

Evguenia Ouchveridze¹, Christopher Booth², Ghulam Rehman Mohyuddin³

¹Department of Hematological Malignancies and Cellular Therapeutics, Kansas University Medical Center, KS, USA.

Journal of Cancer Policy

|January 25, 2023

Summary

No abstract available in PubMed .

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

Related Experiment Videos

Last Updated: Aug 12, 2025

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018